Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03757715 · ClinicalTrials.gov registry record · Phase 4
Regional Anesthesia to Reduce Opioid Use Following Functional Endoscopic Sinus Surgery
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT03757715 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 46 participants.
The verdict
NCT03757715, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
Opioids are prescribed for moderate to severe pain disorders; however, there are contraindications and side effects that are common to all opioids. The investigators hypothesize using regional anesthetic during sinus surgery will reduce surgical pain, therefore decreasing the need for post-operative opioid medication. The primary of objective is to determine if a long-acting local regional anesthetic applied during a surgery will reduce post-operative oral opioid usage.
Interventions
- DRUG Bupivacaine
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2021-04-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03757715
The ClinicalTrials.gov registry entry for NCT03757715 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03757715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03757715 about?
NCT03757715 is a clinical study titled "Regional Anesthesia to Reduce Opioid Use Following Functional Endoscopic Sinus Surgery". Opioids are prescribed for moderate to severe pain disorders; however, there are contraindications and side effects that are common to all opioids. The investigators hypothesize using regional anesthetic during sinus surgery will reduce surgical pain, therefore decreasing the need for post-operative...
What is the current status of trial NCT03757715?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2019-05-20. Estimated completion is 2021-04-12.
What interventions are being tested in trial NCT03757715?
The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03757715?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.